Characteristic | Group | P value | |
---|---|---|---|
OIT (N = 31) | Untreated (N = 17) | ||
Gender (male) | 23 | 14 | 0.396 |
Age at the challenge test | |||
Median | 9 | 7 | 0.179 |
Range | (5–17) | (5–16) | |
Initial total IgE level (IU/mL) | |||
Median | 871 | 935 | 0.940 |
Range | (90–21966) | (122.7–30725) | |
Initial CM-specific IgE level (kUA/L) | |||
Median | 25 | 29 | 0.407 |
Range | (0.9–5730) | (0.56–6290) | |
Initial casein-IgE level (kUA/L) | |||
Median | 21.5 | 28.4 | 0.693 |
Range | (1.1–7210) | (1.12–8350) | |
Initial β-lactoglobulin-IgE level (kUA/L) | |||
Median | 2 | 1.05 | 0.425 |
Range | (0–61.8) | (0.05–75.3) | |
Presence of other food allergiesa | |||
No | 10 (32%) | 3 (18%) | 0.229 |
Yes | 21 (68%) | 14 (82%) | |
Frequency of anaphylaxis at accidental ingestion | |||
Never | 9 (29%) | 2 (12%) | 0.109 |
Once | 12 (39%) | 6 (35%) | |
2–10 times | 10 (32%) | 9 (53%) | |
>10 times | 0 | 0 | |
Atopic dermatitis | 13 | 18 | 0.48 |
Asthma | |||
Severity of asthmaa | 14 (80%) | 10 (59%) | 0.376 |
Intermittent | 3 (45%) | 2 (12%) | |
Moderate | 11 (35%) | 8 (47%) | |
Persistent | 0 | 0 | |
Threshold dose of CM at OFC (mL) | |||
Median | 2 | 2 | 0.337 |
Range | (0.1–40) | (0.5–10) | |
Grade of allergic reaction at OFCb | |||
1 | 8 (26%) | 2 (12%) | 0.823 |
2 | 13 (42%) | 12 (71%) | |
3 | 6 (19%) | 3 (18%) | |
4 | 4 (13%) | 0 (0%) |